SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-281202
Filing Date
2022-11-09
Accepted
2022-11-09 16:07:39
Documents
79
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d265995d10q.htm   iXBRL 10-Q 1231212
2 EX-31.1 d265995dex311.htm EX-31.1 9970
3 EX-31.2 d265995dex312.htm EX-31.2 9955
4 EX-32.1 d265995dex321.htm EX-32.1 4012
5 EX-32.2 d265995dex322.htm EX-32.2 3986
  Complete submission text file 0001193125-22-281202.txt   5879217

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20220930.xsd EX-101.SCH 53368
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20220930_cal.xml EX-101.CAL 49604
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20220930_def.xml EX-101.DEF 177700
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20220930_lab.xml EX-101.LAB 382143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20220930_pre.xml EX-101.PRE 301865
73 EXTRACTED XBRL INSTANCE DOCUMENT d265995d10q_htm.xml XML 943640
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 221372578
SIC: 2834 Pharmaceutical Preparations